Author

G. Menichetti

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Biochemistry· 1 Bioengineering· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:statistical model· 3 Assay:bulk RNA-seq· 1 Research Focus:cell signaling & trafficking· 1 Research Focus:chromatin & epigenetic regulation· 1 Approach:deep learning· 1 Research Focus:drug response / drug discovery· 1 Organism:human· 1 Assay:metabolomics· 1

Frequent Co-Authors

A.-L. Barabasi· 2 shared A. Mugler· 1 shared C. J. Donahue· 1 shared C. O'Leary· 1 shared D. Anderson· 1 shared D. M. Gysi· 1 shared F. Ambrosio· 1 shared F. Wagner· 1 shared

Activity by Year

2021-2022 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersBiochemistry

A.-L. Barabasi

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Estimating Nutrient Concentration in Food Using Untargeted Metabolomics

M. L. Sebek, G. Menichetti, A.-L. Barabasi

This paper estimates nutrient concentrations in food using untargeted metabolomics by leveraging universal scaling, validated on 20 raw foods with high agreement between predictions and experiments.

bioRxiv · Dec 2, 2022 · PreprintBiochemistry

The fidelity of genetic information transfer with aging skeletal muscle segregates according to biological processes

S. Sivakumar, R. LeFebre, G. Menichetti, H. IIjima, A. Mugler, F. Ambrosio

The paper quantifies age-related decline in transcription factor-target gene communication efficiency using single-cell RNA-seq data from skeletal muscle.

bioRxiv · Jul 18, 2022 · PreprintBioengineering

Identification of druggable host targets needed for SARS-CoV-2 infection by combined pharmacological evaluation and cellular network directed prioritization both in vitro and in vivo.

J. Patten, P. T. Keiser, D. M. Gysi, G. Menichetti, H. Mori, C. J. Donahue, X. Gan, I. F. do Valle, K. Geoghegan-Barek, M. Anantpadma, R. Boytz, J. L. Berrigan, S. Hulsey-Stubbs, K. T. Ayazika, C. O'Leary, , R. A. Davey

The paper identifies 389 small molecules and 813 host targets that inhibit SARS-CoV-2 infection through in vitro and in vivo testing, using computational integration of drug activity and cellular networks.

bioRxiv · Apr 20, 2021 · PreprintMicrobiology